Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protocadherin beta-12 is a single-pass transmembrane protein and a member of the protocadherin beta gene cluster located on human chromosome 5. It contains six extracellular cadherin domains and a unique cytoplasmic tail that distinguishes it from other cadherins. Protocadherin beta-12 is most likely involved in calcium-dependent homophilic cell-cell adhesion in neural tissues, contributing to the specificity of synaptic connections necessary for neural circuit development and maintenance. The molecular organization and functional properties of the protocadherin clusters resemble those of immune receptors, but the precise physiological role of protocadherin beta-12 remains unclear, with no current evidence for therapeutic targeting. If you require further details about protein sequence, structure, or interactome, these entries can be found in UniProt (Q9Y5F1) or via genome databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protocadherin beta-12 (PCDHB12).